Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

New weight-loss pills cause weight loss almost four times as fast as Ozempic and similar injectable treatments ...

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

The CDC defines obesity as having a body mass index (BMI) of at least 30, and a shocking 20% of Americans meet that criteria, with the Midwest and the South reporting the highest levels of weight.

Sep. 18, 2024 — A study more closely links obesity to dementia, finding that leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white ...

12. According to our analysis, however, the national average obesity rate has fallen slightly, from 33.9% in 2022 to 33.6% last year. The latest statistics are cold comfort to experts, who tell ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...